Total Payments
$2,939
2024 Payments
$282.02
Companies
31
Transactions
155
Medicare Patients
31,329
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$2,857 (97.2%)
Education$82.67 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,857 | 145 | 97.2% |
| Education | $82.67 | 10 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $428.62 | 20 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $356.14 | 18 | $0 (2019) |
| Amgen Inc. | $334.45 | 13 | $0 (2022) |
| Relypsa, Inc. | $329.22 | 20 | $0 (2020) |
| Travere Therapeutics, Inc. | $210.25 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $178.87 | 10 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $130.78 | 6 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $116.07 | 8 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $98.80 | 4 | $0 (2023) |
| Genentech USA, Inc. | $82.80 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $282.02 | 17 | Travere Therapeutics, Inc. ($89.17) |
| 2023 | $205.00 | 9 | Travere Therapeutics, Inc. ($121.08) |
| 2022 | $407.48 | 19 | Aurinia Pharma U.S., Inc. ($99.55) |
| 2021 | $118.14 | 6 | AstraZeneca Pharmaceuticals LP ($35.93) |
| 2020 | $95.14 | 6 | Relypsa, Inc. ($52.90) |
| 2019 | $633.82 | 35 | Otsuka America Pharmaceutical, Inc. ($181.31) |
| 2018 | $512.13 | 28 | Otsuka America Pharmaceutical, Inc. ($162.88) |
| 2017 | $685.68 | 35 | Amgen Inc. ($210.69) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 7 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 01/23/2017 | Amgen Inc. | Sensipar (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Nephrology | ||||||
| 01/19/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 01/12/2017 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Hyperparathyroidism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 7,078 | 11,513 | $2.4M | $333,902 |
| 2022 | 49 | 8,828 | 18,486 | $1.3M | $350,519 |
| 2021 | 45 | 7,462 | 16,314 | $1.2M | $318,749 |
| 2020 | 43 | 7,961 | 23,642 | $1.3M | $340,705 |
Total Patients
31,329
Total Services
69,955
Medicare Billing
$1.3M
Procedure Codes
180
All Medicare Procedures & Services
180 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 500 | 634 | $445,106 | $52,541 | 11.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 215 | 581 | $384,192 | $51,175 | 13.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 27 | 178 | $348,809 | $47,665 | 13.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 105 | 467 | $160,583 | $21,185 | 13.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 379 | 477 | $118,143 | $19,189 | 16.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 102 | 456 | $120,931 | $16,007 | 13.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 105 | 108 | $104,108 | $13,624 | 13.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 86 | 360 | $94,219 | $12,625 | 13.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 299 | 349 | $61,982 | $10,073 | 16.3% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 323 | 414 | $46,004 | $7,465 | 16.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 126 | $55,369 | $7,427 | 13.4% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 19 | 1,000 | $49,500 | $5,685 | 11.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 530 | 746 | $34,779 | $5,659 | 16.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 373 | 545 | $34,531 | $5,622 | 16.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 26 | $42,288 | $5,615 | 13.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 59 | 104 | $41,377 | $5,416 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 438 | 568 | $10,224 | $4,764 | 46.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 280 | 280 | $28,090 | $4,721 | 16.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 58 | 154 | $33,467 | $4,587 | 13.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 35 | $34,497 | $4,248 | 12.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 527 | 740 | $22,559 | $4,178 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $32,888 | $3,958 | 12.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 526 | 735 | $22,844 | $3,725 | 16.3% |
| 84100 | Phosphate level | Office | 2023 | 357 | 504 | $14,334 | $2,331 | 16.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $17,304 | $2,188 | 12.6% |
About Dr. John Mccarley, M.D
Dr. John Mccarley, M.D is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760480321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mccarley, M.D has received a total of $2,939 in payments from pharmaceutical and medical device companies, with $282.02 received in 2024. These payments were reported across 155 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,857).
As a Medicare-enrolled provider, Mccarley has provided services to 31,329 Medicare beneficiaries, totaling 69,955 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 180 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 07/08/2005
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1760480321
Products in Payments
- ACTHAR (Biological) $436.36
- Veltassa (Drug) $383.93
- JYNARQUE (Drug) $261.54
- Parsabiv (Biological) $258.10
- SAMSCA (Drug) $167.08
- LUPKYNIS (Drug) $130.78
- LOKELMA (Drug) $111.96
- Rayaldee (Drug) $100.89
- Rituxan (Biological) $82.80
- Kerendia (Drug) $70.39
- ULTOMIRIS (Biological) $67.68
- INJECTAFER (Drug) $47.32
- Parsabiv (Drug) $38.68
- Sensipar (Drug) $37.67
- PURIFIED CORTROPHIN GEL (Drug) $37.53
- BENLYSTA (Biological) $36.00
- INVOKANA (Drug) $31.95
- FARXIGA (Drug) $30.54
- NATPARA (Drug) $28.96
- KRYSTEXXA (Biological) $28.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449
Claude Galphin, Md, MD
Nephrology — Payments: $2,379
Nephrology $2,379